FDA Mission Should Not Include Rx Cost Effectiveness, Rep. Allen Says

Comparative studies should be "untainted" by industry's influence, the Maine Democrat says. He urges full appropriation of funding to AHRQ under the new Medicare law.

More from Archive

More from Pink Sheet